Blackstone’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Blackstone's ADRX Position: Q3 2026 in Review
Blackstone opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 421,701 shares worth $8.41M. The stake represents 0.02% of the portfolio and ranks #91 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Blackstone held 421,701 shares of ADARx Pharmaceuticals worth $8.41M as of Q3 2026.
- ADARx Pharmaceuticals was a new Blackstone position in Q3 2026.
- ADARx Pharmaceuticals made up 0.02% of Blackstone's portfolio in Q3 2026, its #91 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.